Test-system for the assessment of GSK-3 inhibitors activity as antihypoxants and endothelial differentiation stimulators <i>in vitro</i>

The present article describes the stages of the development of the test-system that allows to research the potency of GSK-3 inhibitors to induce endothelial progenitor differentiation and to increase cell survival in hypoxia in vitro. β4-thymosin, which shows anti-ischemic and angiogenic activity, h...

Full description

Bibliographic Details
Main Authors: Yu. E. Burda, S. V. Nadezhdin, E. V. Zubareva, M. V. Pokrovsky, S. Yu. Burda, M. S. Shirina
Format: Article
Language:Russian
Published: OOO “Vashe Tsifrovoe Izdatelstvo” 2018-02-01
Series:Ведомости Научного центра экспертизы средств медицинского применения
Subjects:
Online Access:https://www.vedomostincesmp.ru/jour/article/view/10
id doaj-e18472b7bc39469683b5cb18300251e4
record_format Article
spelling doaj-e18472b7bc39469683b5cb18300251e42021-07-28T14:04:06ZrusOOO “Vashe Tsifrovoe Izdatelstvo”Ведомости Научного центра экспертизы средств медицинского применения1991-29192619-11722018-02-010129328Test-system for the assessment of GSK-3 inhibitors activity as antihypoxants and endothelial differentiation stimulators <i>in vitro</i>Yu. E. Burda0S. V. Nadezhdin1E. V. Zubareva2M. V. Pokrovsky3S. Yu. Burda4M. S. Shirina5Belgorod State National Research UniversityBelgorod State National Research UniversityBelgorod State National Research UniversityBelgorod State National Research UniversityKursk State Medical UniversityBelgorod State National Research UniversityThe present article describes the stages of the development of the test-system that allows to research the potency of GSK-3 inhibitors to induce endothelial progenitor differentiation and to increase cell survival in hypoxia in vitro. β4-thymosin, which shows anti-ischemic and angiogenic activity, has been used a reference preparation. The proposed experimental cell model can be useful in the preliminary testing of new chemical compounds in terms of their ability to treat ischemic disorders and it can be used as an alternative for procedures involving animal testing.https://www.vedomostincesmp.ru/jour/article/view/10киназа гликогенсинтазы-3gsk-3β4-тимозингипоксияишемияэндотелийglycogen synthase kinase 3gsk-3β4-thymosinhypoxiaischemiaendothelium
collection DOAJ
language Russian
format Article
sources DOAJ
author Yu. E. Burda
S. V. Nadezhdin
E. V. Zubareva
M. V. Pokrovsky
S. Yu. Burda
M. S. Shirina
spellingShingle Yu. E. Burda
S. V. Nadezhdin
E. V. Zubareva
M. V. Pokrovsky
S. Yu. Burda
M. S. Shirina
Test-system for the assessment of GSK-3 inhibitors activity as antihypoxants and endothelial differentiation stimulators <i>in vitro</i>
Ведомости Научного центра экспертизы средств медицинского применения
киназа гликогенсинтазы-3
gsk-3
β4-тимозин
гипоксия
ишемия
эндотелий
glycogen synthase kinase 3
gsk-3
β4-thymosin
hypoxia
ischemia
endothelium
author_facet Yu. E. Burda
S. V. Nadezhdin
E. V. Zubareva
M. V. Pokrovsky
S. Yu. Burda
M. S. Shirina
author_sort Yu. E. Burda
title Test-system for the assessment of GSK-3 inhibitors activity as antihypoxants and endothelial differentiation stimulators <i>in vitro</i>
title_short Test-system for the assessment of GSK-3 inhibitors activity as antihypoxants and endothelial differentiation stimulators <i>in vitro</i>
title_full Test-system for the assessment of GSK-3 inhibitors activity as antihypoxants and endothelial differentiation stimulators <i>in vitro</i>
title_fullStr Test-system for the assessment of GSK-3 inhibitors activity as antihypoxants and endothelial differentiation stimulators <i>in vitro</i>
title_full_unstemmed Test-system for the assessment of GSK-3 inhibitors activity as antihypoxants and endothelial differentiation stimulators <i>in vitro</i>
title_sort test-system for the assessment of gsk-3 inhibitors activity as antihypoxants and endothelial differentiation stimulators <i>in vitro</i>
publisher OOO “Vashe Tsifrovoe Izdatelstvo”
series Ведомости Научного центра экспертизы средств медицинского применения
issn 1991-2919
2619-1172
publishDate 2018-02-01
description The present article describes the stages of the development of the test-system that allows to research the potency of GSK-3 inhibitors to induce endothelial progenitor differentiation and to increase cell survival in hypoxia in vitro. β4-thymosin, which shows anti-ischemic and angiogenic activity, has been used a reference preparation. The proposed experimental cell model can be useful in the preliminary testing of new chemical compounds in terms of their ability to treat ischemic disorders and it can be used as an alternative for procedures involving animal testing.
topic киназа гликогенсинтазы-3
gsk-3
β4-тимозин
гипоксия
ишемия
эндотелий
glycogen synthase kinase 3
gsk-3
β4-thymosin
hypoxia
ischemia
endothelium
url https://www.vedomostincesmp.ru/jour/article/view/10
work_keys_str_mv AT yueburda testsystemfortheassessmentofgsk3inhibitorsactivityasantihypoxantsandendothelialdifferentiationstimulatorsiinvitroi
AT svnadezhdin testsystemfortheassessmentofgsk3inhibitorsactivityasantihypoxantsandendothelialdifferentiationstimulatorsiinvitroi
AT evzubareva testsystemfortheassessmentofgsk3inhibitorsactivityasantihypoxantsandendothelialdifferentiationstimulatorsiinvitroi
AT mvpokrovsky testsystemfortheassessmentofgsk3inhibitorsactivityasantihypoxantsandendothelialdifferentiationstimulatorsiinvitroi
AT syuburda testsystemfortheassessmentofgsk3inhibitorsactivityasantihypoxantsandendothelialdifferentiationstimulatorsiinvitroi
AT msshirina testsystemfortheassessmentofgsk3inhibitorsactivityasantihypoxantsandendothelialdifferentiationstimulatorsiinvitroi
_version_ 1721268642130165760